These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 11319244

  • 1. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
    Kim D, Thayer SA.
    J Neurosci; 2001 May 15; 21(10):RC146. PubMed ID: 11319244
    [Abstract] [Full Text] [Related]

  • 2. Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures.
    Kim DJ, Thayer SA.
    Brain Res; 2000 Jan 10; 852(2):398-405. PubMed ID: 10678767
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
    Terranova JP, Michaud JC, Le Fur G, Soubrié P.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov 10; 352(5):576-9. PubMed ID: 8751088
    [Abstract] [Full Text] [Related]

  • 4. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S, Venance L, Torrens Y, Cordier J, Glowinski J, Giaume C.
    Eur J Neurosci; 1999 Feb 10; 11(2):691-9. PubMed ID: 10051770
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
    Lees G, Dougalis A.
    Brain Res; 2004 Jan 30; 997(1):1-14. PubMed ID: 14715144
    [Abstract] [Full Text] [Related]

  • 6. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.
    Hoffman AF, Oz M, Caulder T, Lupica CR.
    J Neurosci; 2003 Jun 15; 23(12):4815-20. PubMed ID: 12832502
    [Abstract] [Full Text] [Related]

  • 7. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses.
    Wilson RI, Nicoll RA.
    Nature; 2001 Mar 29; 410(6828):588-92. PubMed ID: 11279497
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A, Wilhelm A, Simmet T.
    Br J Pharmacol; 1999 Apr 29; 126(8):1831-9. PubMed ID: 10372827
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.
    Twitchell W, Brown S, Mackie K.
    J Neurophysiol; 1997 Jul 29; 78(1):43-50. PubMed ID: 9242259
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
    Szabo B, Siemes S, Wallmichrath I.
    Eur J Neurosci; 2002 Jun 29; 15(12):2057-61. PubMed ID: 12099913
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
    Hampson RE, Miller F, Palchik G, Deadwyler SA.
    Neuropharmacology; 2011 May 29; 60(6):944-52. PubMed ID: 21288475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.